It is my observation that those who sell such stocks to wait for a more suitable time to buy back these same shares seldom attain their objective. They usually wait for a decline to be bigger than it actually turns out to be. - The Patriarch of Growth Investing (Phillip Fisher)
Since I recommended Amicus Therapeutics (FOLD) to my private investment community Integrated BioSci Investing, the stock has delivered over 40% profits for members. Nevertheless, there are significant upsides due to strong ongoing fundamental developments. As the pioneer of a novel approach toward